Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IWWM-12 2024 | Using single-cell multi-omics to understand the progression from MGUS to WM

Carmen González Días-Cano, MSc, PhD(c), University of Navarra, Pamplona, Spain, discusses the value of single-cell multi-omics studies to characterize cell phenotypes. She mentions how differences between cell expression in Waldenström’s macroglobulinemia (WM) and monoclonal gammopathy of undetermined significance (MGUS) could be used to understand the progression from MGUS to WM. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.